Novacyt gets PHE order for Covid-19 tests
16th Mar 2020 09:46
(Sharecast News) - Novacyt said on Monday that Public Health England has decided to use a Covid-19 test developed by its molecular diagnostics division, Primerdesign.
Read moreNovacyt increases manufacturing capacity for Covid-19 test
12th Mar 2020 12:27
(Sharecast News) - Clinical diagnostics company Novacyt updated the market on its Covid-19 coronavirus test, developed by its molecular diagnostics division Primerdesign, on Thursday.
Read moreNovacyt shares surge on demand for Covid-19 test
28th Feb 2020 09:52
(Sharecast News) - Clinical diagnostics company Novacyt updated the market on its novel Covid-19 coronavirus test developed by its molecular diagnostics division Primerdesign on Friday.
Read moreNovacyt reports solid demand for coronavirus test
7th Feb 2020 14:11
(Sharecast News) - Clinical diagnostics company Novacyt updated the market on the launch of its research-use only test for the Wuhan novel coronavirus strain, or 2019-nCoV, which was developed by its subsidiary Primerdesign as a direct response to the recent outbreak of the respiratory virus in China.
Read moreNovacyt shares soar as it launches test for Wuhan coronavirus
31st Jan 2020 15:35
(Sharecast News) - Clinical diagnostics company Novacyt announced on Friday that its molecular diagnostics division Primerdesign has launched a new molecular test for novel coronavirus, or '2019-nCoV'.
Read moreNovacyt division signs distribution deal with VGS Group
17th Jan 2020 11:31
(Sharecast News) - Clinical diagnostics specialist Novacyt announced on Friday that its molecular testing division, Primerdesign, has signed an exclusive commercial agreement with Atothis - part of VGS Group - for the distribution of certain molecular diagnostic products in France, for the aquaculture and aquamarine markets.
Read moreNovacyt sells 'NOVAprep' business to Algimed Trade
27th Dec 2019 15:36
(Sharecast News) - Clinical diagnostics specialist Novacyt has completed the sale of 'NOVAprep' assets to Algimed Trade, it announced on Friday, for a total consideration of €0.4m and a 10% royalty on sales in certain defined territories.
Read moreNovacyt announces new molecular diagnostic multiplex test
7th Oct 2019 15:35
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the successful development of a new molecular diagnostic multiplex test for respiratory infections on Monday, which it said was ready for launch in North America in time for the United States cold and flu season.
Read moreNovacyt trading in line as it seeks fresh funding
26th Feb 2019 15:47
(Sharecast News) - Clinical diagnostics specialist Novacyt updated the market on its current position and funding plans on Tuesday, confirming that 2019 trading had started positively and was in line with 2019 management expectations.
Read moreNovacyt launches two new CE-marked molecular products
21st Dec 2018 14:31
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the launch of new CE-marked approved molecular products, the 'genesig' Real-Time PCR BK virus (BKV) kit and the 'genesig' Real-Time PCR Epstein-Barr Virus (EBV) kit.
Read moreNovacyt stumbles as Novaprep business tanks
2nd Aug 2018 11:58
(Sharecast News) - Novacyt on Thursday confirmed that it will carry out a strategic review after reporting that full-year group revenue will be lower than previously expected due to losses in its Novaprep business.
Read more